The objectives of this powerpoint include:
- Recognizing skin and soft tissue infections in people who inject drugs
- Educate individuals about risk factors and risk groups for Hepatitis C and HOV
- Describe prevention interventions for HCV and HIV including effective addiction treatment, behavioral risk reduction, and antiviral agents.
- Discuss how treatment regimens for both HCV and HIV are highly effective in patients with OUD and can be safely used with opiod agonist therapy.
Funding for this initiative was made possible by grant no. 1H79TI083022 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
